pFLAG AXL Citations (3)

Originally described in: Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
Krishnamoorthy GP, Guida T, Alfano L, Avilla E, Santoro M, Carlomagno F, Melillo RM J Biol Chem. 2013 Jun 14;288(24):17481-94. doi: 10.1074/jbc.M112.439422. Epub 2013 Apr 29. PubMed Journal

---

Articles Citing pFLAG AXL

Articles
beta-Catenin Restricts Zika Virus Internalization by Downregulating Axl. Jimenez OA, Narasipura SD, Barbian HJ, Albalawi YA, Seaton MS, Robinson KF, Al-Harthi L. J Virol. 2021 Aug 10;95(17):e0070521. doi: 10.1128/JVI.00705-21. Epub 2021 Aug 10. PubMed
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2. Novoyatleva T, Rai N, Kojonazarov B, Veeroju S, Ben-Batalla I, Caruso P, Shihan M, Presser N, Gotz E, Lepper C, Herpel S, Manaud G, Perros F, Gall H, Ghofrani HA, Weissmann N, Grimminger F, Wharton J, Wilkins M, Upton PD, Loges S, Morrell NW, Seeger W, Schermuly RT. Commun Biol. 2021 Aug 24;4(1):1002. doi: 10.1038/s42003-021-02531-1. PubMed
The FAP alpha -activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway. Ye G, Huang M, Li Y, Ouyang J, Chen M, Wen Q, Li X, Zeng H, Long P, Fan Z, Yin J, Ye W, Zhang D. Acta Pharm Sin B. 2022 Mar;12(3):1288-1304. doi: 10.1016/j.apsb.2021.08.015. Epub 2021 Aug 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.